Analysis of butyrophenones in whole blood specimens by LC/MS/MS using a new polymer column

Japanese Journal of Forensic Toxicology

Volumn 23, Issue 1, 2005, Pages 13-17

  Hattori, Hideki ^a   Arinobu, Tetsuya ^a   Iwai, Masae ^a   Masuda, Kenji ^a   Suzuki, Osamu ^b   Seno, Hiroshi ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bromperidol; Butyrophenones; Haloperidol; LC MS MS; Moperone; New polymer column (MSpak GF 310); Spiroperidol; Whole blood

Indexed keywords

BROMPERIDOL; BUTYROPHENONE; HALOPERIDOL; MOPERONE; PIMOZIDE; POLYMER; SPIPERONE; TIMIPERONE;

ANALYTIC METHOD; ARTICLE; CALIBRATION; DRUG BLOOD LEVEL; DRUG STRUCTURE; FORENSIC MEDICINE; HUMAN; LABORATORY TEST; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; STANDARD;

EID: 16844373383     PISSN: 09159606     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. 18 cartridges and wide-bore capillary gas chromatography of some butyrophenones. Z Rechtsmed, 102, 127-132 (1989).
2. Tydale RF, Inaba T: Simultaneous determination of haloperidol and reduced haloperidol by gas chromatography using a megabore column with electron-capture detection: application to microsomal oxidation of reduced haloperidol. J Chromatogr, 529, 182-188 (1990).
3. Ulrich S, Meyer FP, Neuhof S, Knorr W: Megabore capillary gas-chromatographic method with nitrogen-phophorus selective detection for the assay of haloperidol in serum: results of therapeutic drug-monitoring during acute therapy of eight schizophrenics. J Chromatogr B, 663, 289-296 (1995).
4. Hattori H, Suzuki O, Brandenberger H: Positive and negative-ion mass spectrometry of butyrophenones. J Chromatogr, 382, 135-145 (1986).
5. Park KH, Lee MH, Lee MG: Simultaneous determination of haloperidol and its metabolite, reduced haloperidol, in plasma, blood, urine and tissue homogenates by high-performance liquid chromatography. J Chromatogr, 572, 259-267 (1991).
6. Ohkubo T, Shimoyama R, Sugawara K: Measurement of haloperidol in human breast milk by high-performance liquid chromatography. J Pharm Sci, 81, 947-949 (1992).
7. Hoffmann DW, Edkins RD: Solid-phase extraction and high-performance liquid chromatography for therapeutic monitoring of haloperidol levels. Ther Drug Monit, 16, 504-508 (1994).
8. Avent KM, Riker RR, Fraser GL, Van der Schyf CJ, Usuki E, Pond SM: Metabolism of haloperidol topyridinium species in patients receiving high doses intravenously: is HPTP an intermediate? Life Sci, 61, 2383-2390 (1997).
9. Walter S, Baner S, Roots I, Brockmöller J: Quantification of the antipsychotics flupentixol and haloperidol in human serum by high-performance liquid chromatography with ultraviolet detection. J Chromatogr B, 720, 231-237 (1998).
10. Pan L, Rosseel MT, Belpaire FM: Comparison of two high-performance liquid chromatographic methods for monitoring plasma concentrations of haloperidol and reduced haloperidol. Ther Drug Monit, 20, 224-229 (1998).
11. Hoja H, Marquet P, Verneuil B, Lotfi H, Dupuy JL, Pénicaut B, Lachâtre G: Determination of haloperidol and its reduced metabolite in human plasma by liquid chromatography-mass spectrometry with electrospray ionization. J Chromatogr B, 688, 275-280 (1997).
12. Arinobu T, Hattori H, Iwai M, Ishii A, Kumazawa T, Suzuki O, Seno H: Liquid chromatographic-mass spectrometric determination of haloperidol and its metabolites in human plasma and urine. J Chromatogr B, 776, 107-113 (2002).
13. Fang J, Gorrod JW, Kajbaf M, Lamb JH, Naylor S: Investigation of the neuroleptic drug haloperidol and its metabolites using tandem mass spectrometry. Int J Mass Spectrom Ion Processes, 122, 121-131 (1992).
14. Verweij AMA, Nordijk ML, Lipman PJL: Liquid chromatographic-thermospray tandem mass spectrometric quantitative analysis of some drugs with hypnotic, sedative and tranquillising properties in whole blood. J Chromatogr B, 686, 27-34 (1996).
15. Hempenius J, Steenvoorden RJJM, Lagerwerf FM, Wieling J, Jonkman JHG: 'High throughput' solid-phase extraction technology and turbo ionspray LC/MS/MS applied to the determination of haloperidol in human plasma. J Pharm Biomed Anal, 20, 889-898 (1999).
16. Seno H, Hattori H, Ishii A, Kumazawa T, Watanabe-Suzuki K, Suzuki O: Analyses of butyrophenones and their analogues in whole blood by high-performance liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr B, 746, 3-9 (2000).
17. Arinobu T, Hattori H, Seno H, Ishii A, Suzuki O: Comparison of SSI with APCI as an interface of HPLC-mass spectrometry for analysis of a drug and its metabolites. J Am Soc Mass Spectrom, 13, 204-208 (2002).
18. Schulz M, Schmoldt A: Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie, 58, 447-474 (2003).
19. Baselt RC: Disposition of Toxic Drugs and Chemicals in Man, 7th ed, Biomedical Publications, Foster City, CA, 2004, pp. 910-911.